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Adenovirus L4-100K Assembly Protein
Is a Granzyme B Substrate that Potently
Inhibits Granzyme B-Mediated Cell Death
lying both of these pathways (Beresford et al., 1999;
reviewed in Budihardjo et al., 1999; Nicholson and
Thornberry, 1997; Salvesen and Dixit, 1997).
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The mechanisms of action of GrA and GrB in cytolysisJohns Hopkins University School of Public Health
remain incompletely understood. Although both gran-Baltimore, Maryland 21205
zymes are involved in processes leading to DNA damage
and/or fragmentation (Anel et al., 1997; Ebnet et al.,
1995; Hayes et al., 1997; Heusel et al., 1994; Shi et al.,Summary
1992; Simon et al., 1997), their actions are phenotypically
and kinetically distinct, implying that they function byCytotoxic lymphocytes kill virus-infected target cells
alternative (distinct) pathways (Beresford et al., 1999;and play a critical role in host recovery from viral infec-
Shresta et al., 1999). Thus, GrA induces single-strandtions. Granzyme B (GrB) is a cytotoxic lymphocyte
DNA breaks and cleavage of PHAP II and histone H1 ingranule protease that plays a critical role in mediating
a caspase-independent manner. In contrast, GrB cata-cytotoxicity. In these studies, we demonstrate that the
lyzes the cleavage and activation of several downstreamadenovirus assembly protein L4–100K (100K) is a GrB
caspases, inducing apoptotic changes in target cellssubstrate that prevents cytotoxic lymphocyte granule-
(reviewed by Salvesen and Dixit, 1997). In addition, likeinduced apoptosis in infected target cells by potently
GrA, GrB can initiate caspase-independent pathways ofinhibiting GrB. This inhibition is absolutely dependent
cell death (MacDonald et al., 1999; Sarin et al., 1997;on Asp-48 in 100K, found within a classic GrB consen-
Talanian et al., 1997). GrB accomplishes this throughsus motif. 100K is the first viral protein described that
direct proteolysis and activation of molecules likeexclusively targets the GrB pathway. It represents a
DFF45/ICAD (Thomas et al., 2000) and cleavage of sev-novel class of viral protease inhibitor, in which an es-
eral substrates involved in cellular homeostasis (Froelichsential, multifunctional viral protein, which is vulnera-
et al., 1996; Andrade et al., 1998; Casciola-Rosen et al.,ble to specific proteolysis by GrB, expresses inhibitory
1999).function against that protease.
At multiple points, viral gene products can interfere
with the orderly execution of apoptosis induced by cyto-Introduction
toxic lymphocytes. Some inhibitors regulate caspase
activation indirectly by modulating upstream signalingThe existence of numerous viral strategies to prevent
pathways, e.g., through forced degradation of Fas (ade-
apoptosis of infected cells underscores the fact that
novirus RID) (Tollefson et al., 1998), direct interaction
proapoptotic pathways are detrimental to the viral life
with, and inhibition of, members of the Fas signaling
cycle, and viral products have evolved to counteract complex (gammaherpesvirus FLIPs and adenovirus E1B
this significant selection pressure. Thus, viruses have 19K) (Imai et al., 1999; Perez et al., 1998; Thome et al.,
coevolved with the immune system to develop strate- 1997), or by expression of antiapoptotic bcl-2 homologs
gies for escaping apoptosis and preventing premature (for example, KSBcl-2 from HHV8, EBV BHRF1, and ade-
death of the host cell, which maximizes virus progeny novirus E1B 19K) (reviewed by Hardwick, 1998), which
from a lytic infection or facilitates a persistent infection likely regulate transduction of proapoptotic signals at
(reviewed in Hardwick, 1998; Tortorella et al., 2000; Tra- the mitochondrial level. Viral proteins can also regulate
pani et al., 1999; Wold et al., 1999). Cytotoxic lympho- apoptosis by directly interacting with either initiator or
cytes represent the primary defense against virus-infected effector caspases. At least three classes of inhibitors
cells (reviewed in Ka¨gi et al., 1995). The cytotoxic ef- have been described, including adenoviral E3 14.7 (Chen
fector cell induces target cell death through pathways et al., 1998), SPIs (serine proteinase inhibitors or serpins)
initiated by the Fas receptor or through granule exo- from poxviruses (reviewed in Bird, 1998), and a family
cytosis (reviewed in Ashkenazi and Dixit, 1998; Henkart, of viral IAPs (inhibitors of apoptosis) (reviewed by Hard-
1994; Nagata, 1999; Podack et al., 1991). Targeted pro- wick, 1998; Deveraux and Reed, 1999).
teolysis of cellular substrates and activation of the cas- While several viral inhibitors can efficiently block cas-
pase family of proteases are central mechanisms under- pase-mediated apoptosis induced by Fas or GrB, viral
inhibitors that efficiently and exclusively block caspase-
independent lymphocyte granule-mediated cell death6 Correspondence: arosen@jhmi.edu
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Figure 1. GC-Induced Cell Death Is Abol-
ished in Ad5-Infected Cells
(A) Mock- or Ad5-infected HeLa cells (24 hr
after infection) were incubated with buffer
alone (panels a and c) or with GC (panels b
and d). After fixation and permeabilization,
cells were stained with the monoclonal anti-
body 37–3 against adenovirus DNA binding
protein (DBP), FITC-goat anti-mouse anti-
bodies to detect Ad5-infected cells, and pro-
pidium iodine (PI) to highlight apoptotic mor-
phology. Merged images show adenovirus
infection (green) as well as cytoplasmic, nu-
clear, and nucleolar RNA (red). GC treatment
induced prominent PI-rich apoptotic surface
blebs (arrowheads) and nuclear condensa-
tion (arrows) in uninfected cells (panel b) (An-
drade et al., 1998), but not in Ad5-infected
cells (panel d). The scale bars indicate 10m.
(B) Normal and apoptotic cells in the GC-
treated mock- and Ad5-infected HeLa cells
(Figure 1A, panels b and d) were counted and
plotted as a percentage of total counted cells.
The analysis of Ad5-infected cells included
only DBP-stained positive cells (90%). The
error bars represent the standard deviation.
(C) Apoptosis was induced in mock- or Ad5-infected HeLa cells by GC treatment or UVB irradiation. Ad5 infection was confirmed by
immunoblotting using the anti-adenovirus monoclonal antibody 1E11 (Advanced Immuno Chemical). PARP was detected by immunoblotting.
The unfilled arrow and the solid arrowhead denote specific PARP fragments generated by caspase-3 and GrB cleavage, respectively. In Ad5-
infected cells, a nonspecific band is present above the GrB fragment of PARP (lanes 4 and 6).
(D) Cleavage of endogenous U1–70 kDa by GrB is inhibited in Ad5-infected HeLa cell lysates. Control or Ad5-infected HeLa cell lysates were
incubated in vitro with GC. U1–70 kDa autoantigen was detected by immunoblotting; the unfilled arrow marks the GrB-specific fragment, and
the arrowhead denotes the fragment generated by caspase-3 cleavage. Similar results were obtained when the cleavage of other GrB substrates
(NuMA, PARP, La, and Mi-2) were analyzed (data not shown). The experiments were repeated on 2–9 separate occasions, with identical
results.
have not been found (Trapani et al., 1999). In addition, ptotic changes were prevented in cells infected with
Ad5 (Figure 1A, panel d), in which GC-treated cells (panelwhereas induction of target cell apoptosis limits viral
replication by preventing completion of the viral life cy- d) appeared identical to infected cells treated with buffer
alone (panel c). The percentage of morphologically apo-cle, it is not yet known if GrB has any direct effect(s) on
viral proteins. ptotic cells in mock- and adenovirus-infected HeLa cells
treated with GC was quantified. While 48% of mock-The current study demonstrates that adenovirus 100K
assembly protein is a potent and specific inhibitor of infected cells had apoptotic morphology at 60 min, only
7% of Ad5-infected cells were similarly affected (p GrB. Inhibition is mediated by rapid binding of GrB to
a consensus cleavage site at IEQD48, which dramatically 0.0001; Chi-square analysis) (Figure 1B). Proteolysis of
signature death substrates is a characteristic feature ofslows the catalytic activity of the protease. Interestingly,
100K is also efficiently cleaved by GrB at a downstream GC-induced death, and we have previously shown that
site (VSGD560↓G), which plays no role in GrB inhibition. GrB directly and efficiently cleaves several downstream
100K represents the first example of an essential viral caspase substrates, generating unique fragments (An-
protein that is susceptible to direct cleavage by effector drade et al., 1998; Casciola-Rosen et al., 1999). When
proteases in cytotoxic granules and prevents GrB-medi- mock-infected cells were exposed to GC, cleavage of
ated caspase activation, direct substrate cleavage, and poly(ADP-ribose) polymerase (PARP) was prominent,
cytotoxic granule-induced cell death. generating a signature 54 kDa C-terminal fragment that
is characteristic of GrB cleavage (Froelich et al., 1996)
Results (Figure 1C, lane 3). However, this GrB-mediated cleav-
age of PARP was absent in Ad5-infected cells exposed
to GC (Figure 1C, compare lanes 3 and 6). In contrast,Adenovirus Encodes an Inhibitor of GrB
Adenoviruses have adopted numerous strategies to pre- caspase-mediated cleavage of PARP (generating the
signature 89 kDa fragment) was evident in both Ad5-vent apoptosis of infected target cells, but no adenoviral
inhibitors of components of the granule pathway have and mock-infected HeLa cells in which apoptosis was
induced by UVB irradiation (Figure 1C, compare lanesbeen described. We initially studied the susceptibility
of adenovirus type 5 (Ad5)-infected cells to cytotoxic 2 and 5). The striking and selective inhibition of GrB-
induced substrate cleavage in Ad5-infected cells maylymphocyte granule-induced apoptosis. In mock-infected
HeLa cells, purified granule contents (GC) from human therefore reflect a direct effect of adenovirus on a com-
ponent of the granule pathway.natural killer (NK) cells, but not buffer alone, induced
rapid onset (60 min) of prominent surface blebbing, To address whether the proteolytic activity of GrB
was altered in lysates of Ad5-infected cells, we directlynuclear condensation, and fragmentation into apoptotic
bodies (Figure 1A, panel b). These GC-induced apo- analyzed the activity of GrB against macromolecular
Granzyme B Inhibition by Adenovirus
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Figure 2. Ad5 100K Assembly Protein Is
Cleaved by GrB In Vitro
(A) Ad5 late proteins were metabolically la-
beled and incubated with 69 nM purified GrB
for 60 min at 37C in the presence of 5 mM
iodoacetamide (to inactivate endogenous
caspase activity). GrB induced significant
degradation of 100K (solid arrow), with the
appearance of new fragments of70, 80, and
95 kDa (unfilled arrows).
(B) [35S]methionine-labeled 100K generated
by IVTT was incubated with purified GrB for
30 min at 37C. The open arrows mark promi-
nent GrB cleavage fragments of 100K (95 and
70 kDa).
(C) GrB inhibition in lysates of Ad5-infected
293T cells coincides with the expression of
100K. Cell lysates were prepared from mock-
and Ad5-infected 293T cells at 8, 16, 24, and
48 hr after infection and incubated with GC
for 1 hr at 37C. PARP and adenoviral 100K
were detected by immunoblotting. The un-
filled arrows denote PARP cleavage frag-
ments (110, 89, and 54 kDa). Similar results
were obtained with NuMA and U1–70 kDa
(data not shown). All results are representa-
tive of at least two separate experiments.
substrates in these lysates. Interestingly, the generation the GrB inhibitory activity, with 100K expression and GrB
inhibition initially detected at 16 hr after Ad5 infectionof signature GrB fragments of U1–70 kDa, NuMA, PARP,
La, and Mi-2 was abolished in lysates made from Ad5- (Figure 2C, compare lanes 2 and 4 to lane 6) and maxi-
mally at 48 hr (Figure 2C, lane 10).infected cells (Figure 1D; data not shown), indicating
that a GrB inhibitory activity was present in infected
cells. To define the adenoviral genes required for pro- 100K Adenovirus Assembly Protein Is a Potent
Inhibitor of Cytotoxic Lymphocyte-Inducedduction of this inhibitory activity, we measured GrB ac-
tivity in lysates of cells infected with different Ad5 early Target Cell Death
Since 100K expression in Ad5-infected cells correlatedgene deletion mutants. Although two viral proteins
(E1B55K and E4-ORF6) were required for generation of precisely with the appearance of GrB inhibitory activity
(Figure 2C, lanes 6, 8, and 10), we performed additionalGrB inhibition, they appeared to be functioning in trans,
through their effect on late gene expression (data not studies to better characterize its role as a candidate
inhibitor of GrB in target cells. Intact HeLa or 293T cellsshown). This was further supported by the observation
that GrB inhibitory activity was absent when 10 mM expressing 100K were exposed to GC. In HeLa cells that
do not express 100K (Figure 3A, panel b), GC inducedhydroxyurea (which inhibits viral DNA replication and
allows only early gene expression, but not late gene the rapid onset (60 min) of apoptotic morphology. In
contrast, these characteristic GC-induced apoptoticexpression) was added to Ad5-infected HeLa cells (Levy
et al., 1968; data not shown). changes were prevented in cells expressing 100K (Fig-
ure 3A, panel b). The effect of 100K on cytotoxic lympho-
cyte granule-induced apoptosis was also quantified byAdenovirus 100K Assembly Protein Is Cleaved by GrB
Adenovirus late genes encode more than 20 products MitoSensor (Clontech) staining. This cationic dye accu-
mulates in the mitochondria of control cells, but not ininvolved in virion assembly and regulation of translation
(reviewed by Shenk, 1996), greatly complicating muta- apoptotic cells, because of altered mitochondrial mem-
brane potential. In vector-transfected 293T cells, GCtional and deletional analyses. Since several protein pro-
tease inhibitors (e.g., serpins) are cleaved by their target induced a significant decrease in cell size, consistent
with death by apoptosis (compare Figure 3B, panels aproteases (Quan et al., 1995; Ray et al., 1992; Sun et al.,
1996; Turner et al., 1999), we determined whether any and c), which was accompanied by loss of MitoSensor
staining (27% of GC-treated cells concentrated Mito-late adenoviral proteins were GrB substrates and might
therefore be candidate GrB inhibitors. Ad5 late proteins Sensor, compared to 85% of cells incubated with buffer
alone) (Figure 3B, panel d and b, respectively). In con-were metabolically labeled, and their susceptibility to
GrB cleavage was assessed in vitro. The 100K adenovi- trast, when cells expressing 100K were exposed to GC,
the decrease in cellular size was not prominent (Figurerus assembly protein was efficiently cleaved by purified
GrB generating fragments of70, 80, and 95 kDa (Figure 3B, panel e), and loss of MitoSensor staining was inhib-
ited (81% of cells expressing 100K exposed to GC still2A, lane 2). Similar fragments were observed when
[35S]methionine-labeled 100K was generated by in vitro concentrated MitoSensor) (Figure 3B, panel f).
To confirm the importance of 100K in GrB inhibition intranscription/translation (IVTT) (Figure 2B). It is notewor-
thy that the time course of expression of 100K in Ad5- adenovirus-infected target cells, the Fas-negative 293T
cell line was infected with wild-type or the temperatureinfected cells correlated exactly with the appearance of
Immunity
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Figure 3. Cytotoxic Lymphocyte Granule-Mediated Cell Death Is Abolished in Cells Expressing 100K Adenovirus Assembly Protein
(A) HeLa cells were transiently transfected with pcDNA3.1-FLAG-100K vector. After 48 hr, the cells were incubated with buffer alone (a) or
GC (b) for 1 hr at 37C, then fixed, permeabilized, and stained with a monoclonal antibody against the FLAG peptide (Stratagene) and FITC-
goat anti-mouse antibodies, as well as PI and DAPI. Merged images of FLAG (green), PI (red), and DAPI (blue) staining are shown. Note that
GC induced prominent surface blebs, nuclear condensation, and fragmentation in cells that do not express FLAG-100K-wt (b), but not cells
expressing FLAG-100K (b). The scale bar indicates 10 m.
(B) 100K assembly protein inhibits GC-mediated alterations in mitochondrial membrane permeability. Vector-transfected 293T cells (panels
a, b, c, and d) and cells expressing 100K (panels e and f) were incubated for 60 min at 37C in the absence (panels a and b) or presence
(panels c, d, e, and f) of GC. After terminating the reactions, samples were incubated for 20 min in the presence of MitoSensor (Clontech) as
recommended by the manufacturer. Fluorescent labeling was evaluated using FACSort equipped with CELLQuest software (Becton Dickinson).
(C) 293T cells were H5ts1-infected (10 pfu/cell) 12 hr after transfection with empty vector or pcDNA3.1–100K and incubated at the nonpermissive
temperature. As controls, 293T cells were mock- or Ad5-infected. At 24 h after infection, cells were incubated alone or coincubated with LAK
cells (an effector:target ratio of 2:1) for 4 hr at 37C. After terminating the reactions, the samples were electrophoresed and immunobloted
with anti-100K (rabbit polyclonal) or patient sera to detect NuMA and PARP.
(D) 293T cells transfected with vector alone or with 100K were incubated in the absence or presence of LAK cells (an effector:target ratio of
5:1) and analyzed as above. The unfilled arrows denote protein fragments. The results shown in all panels are representative of at least two
separate experiments.
sensitive (ts) 100K mutant adenovirus H5ts1 (Hayes et was abolished in target cells expressing 100K (Figure
3D, lane 5). In summary, 100K expression in target cellsal., 1990) prior to exposure to lymphokine-activated
killer (LAK) cells. Coincubation of LAK cells with mock- prevents typical apoptotic morphology, altered mito-
chondrial membrane potential, and characteristic GrB-or H5ts1-infected target cells resulted in characteristic
NuMA and PARP cleavage (Figure 3C, lanes 3 and 5, induced cleavage of death substrates during cytotoxic
lymphocyte granule-mediated killing and during LAK-respectively), which was abolished in Ad5-infected cells
(Figure 3C, lane 4). Substrate cleavage was also abol- induced target cell death. These data, therefore, demon-
strate that 100K alone exhibits identical inhibitory ef-ished in H5ts1-infected cells in which 100K expression
was reestablished by transfection with 100K (Figure 3C, fects on the cytotoxic granule-induced death pathway,
as were observed in Ad5-infected target cells (Figure 3).lane 6). Since the 100K mutant virus is also defective in
the expression of other late proteins (Cepko and Sharp,
1982; Hayes et al., 1990; Riley and Flint, 1993), which Asp-48 Is a Critical Residue for 100K-Mediated
Inhibition of GrBcould play a role in GrB inhibition and might be induced
during 100K rescue of the H5ts1 virus (see Figure 6), we Since 100K is cleaved by GrB, we addressed whether
cleavage of 100K was required for GrB inhibition. Usingalso directly addressed whether 100K expression alone
in target cells could inhibit LAK-mediated killing. When the tetrapeptide specificity of GrB (Thornberry et al.,
1997; Harris et al., 1998) to predict potential GrB cleav-effector and target cells were coincubated at a 5:1 ratio,
characteristic NuMA and PARP cleavage was observed age sites in 100K, relevant P1 aspartic acids were mu-
tated to alanine, and the susceptibility of wild-type and(Figure 3D, lane 4). In contrast, apoptotic proteolysis
Granzyme B Inhibition by Adenovirus
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Figure 4. Asp-48 Is a Critical Residue for
100K-Mediated GrB Inhibition of GC-Medi-
ated Cell Death
(A) GrB cleavage sites in 100K were defined
by mutating P1 aspartic acid residues to ala-
nine and incubating wild-type (wt) and mu-
tated [35S]methionine-labeled products with
GC for 1h at 37C. The solid arrow marks the
position of the intact molecule; the unfilled
arrows denote the 95 and 70 kDa GrB frag-
ments. The generation of the 95 and 70 kDa
fragments is abolished by mutation at D48 and
D560, respectively.
(B) Mock-transfected 293T cells (lanes 1 and
2) and cells expressing FLAG-100K-wt (lanes
3 and 4) or FLAG-100K-D48A (lanes 5 and 6)
were incubated for 90 min at 37C with GC.
Samples were immunoblotted with anti-FLAG
antibody (Stratagene), antibodies to caspase-9 and active caspase-3 (New England BioLabs), or patient serum to detect U1–70 kDa. The
unfilled arrows denote protein fragments. The results shown in (A) and (B) are representative of two separate experiments.
mutated forms of 100K to cleavage by GrB was then return of catalytic activity (Figure 5B) demonstrates that
the kcat for the turnover of the enzyme-inhibitor complexassessed. The two sites in 100K that are most efficiently
cleaved by GrB were defined as IEQD48↓P and VSGD560↓G. to inactive products is 5  105 s1, corresponding to
a half-life of 3 hr for the complex. This compares to aThus, generation of the 95 kDa fragment of 100K was
abolished when Asp-48 was changed to Ala (100K-D48A) half-life of 1 s for the complex of GrB with the tetrapep-
tide substrate Ac-IETD-AMC. In contrast to the potent(Figure 4A, compare lanes 2 and 4), and production
of the 70 kDa fragment was abolished by the D560→A inhibition by wild-type 100K, there was no detectable
inhibition by the 100K-D48A mutant, even up to 30 nMmutation (100K-D560A) (Figure 4A, compare lanes 2 and 6).
When cells expressing wild-type 100K were incubated (data not shown).
The specificity of the inhibitory activity of 100K forin the presence of GC, GrB-induced activation of cas-
pase-3 and caspase-9 was abolished, as was the cleav- GrB was tested by performing similar experiments with
purified caspases (caspases 1–13). 100K did not inhibitage of the downstream substrate U1–70 kDa (Figure 4B,
lane 4). Similar data was obtained with cells expressing these cysteine proteases, even using a 10-fold molar
excess of the inhibitor (data not shown).the 100K-D560A mutant (data not shown). In contrast,
when vector-transfected cells or cells expressing 100K- To better understand the slow return of GrB activity,
we studied the biochemical state of 100K and its D48AD48A mutant were exposed to GC, no GrB inhibition was
observed, and caspase-3, caspase-9, and U1–70 kDa mutant over time. When equimolar concentrations of
r100K-wt were incubated with GrB, 100K was slowlywere all efficiently cleaved (Figure 4B, lanes 2 and 6,
respectively). These data strongly suggest that Asp-48 cleaved by the protease (Figure 5C), with a time-course
correlating well with the half-life for the enzyme-inhibitoris a critical residue in the reactive site loop of 100K.
complex shown in Figure 5B (3 hr). In contrast to the
wild-type 100K, the noninhibitory r100K-D48A mutant100K Adenovirus Assembly Protein: Mechanism
of GrB Inhibition was rapidly cleaved by GrB at other sites (including Asp-
560), with a second-order rate constant kcat/Km  1 The potency and mechanism of inhibition of GrB by 100K
were investigated further with purified components in vitro. 105 M1 s1 (Figure 5C). In contrast to some of the more
extreme examples of serpin-serine protease interac-GrB activity was monitored in a continuous fluorescence
assay using the tetrapeptide substrate Ac-IETD-amino- tions that are known (Quan et al., 1995; Sun et al., 1996;
Turner et al., 1999), no sodium dodecyl sulfate (SDS)-methylcoumarin (Ac-IETD-AMC). A collection of time
courses at 3 nM enzyme and 0–7 nM purified recombinant stable complex between GrB and r100K-wt, or its frag-
ments, could be demonstrated by immunoblotting (data100K (r100K) is shown in Figure 5A. In the presence of
inhibitor, the inhibition was established instantly, but the not shown).
enzymatic activity slowly returned to the control velocity
with time. The greater the excess of inhibitor over enzyme, A Vast Molar Excess of 100K Compared to GrB
Exists in Infected Target Cells Undergoingthe longer the lag before enzymatic activity began to return.
Several conclusions may be drawn from these time Granule-Induced Cytotoxicity
100K is a potent inhibitor of GrB; however, this inhibitorycourses. First, in this and other experiments, the rapid
initial inhibition seen at 1 nM inhibitor (half-life  1 min) activity is reversible after several hours, as a result of
100K cleavage. The length of the lag before the returnimplies that the second-order rate constant for associa-
tion is1 107 M1 s1, which approaches the diffusion- of GrB activity is directly related to the excess of inhibitor
relative to GrB, since the saturated protease exhibitscontrolled limit. Second, even a small excess of inhibitor
above the enzyme concentration causes 100% inhibi- zero-order kinetics. This lag is given by the formula: t 
(moles excess inhibitor)/(kcat  E). The ratio of inhibitortion initially, such that it essentially titrates the enzyme at
nanomolar levels. Thus, Ki (or Km) for the initial interaction to GrB in infected target cells undergoing lymphocyte
granule-induced apoptosis therefore provides an esti-must be 	1 nM. Third, analysis of time courses for the
Immunity
756
Figure 5. Analysis of the Interaction between GrB and 100K
(A) The kinetic analysis of the inhibition of GrB by 100K. A collection of time courses from a continuous fluorescence assay observed at 3
nM enzyme and 0–7 nM purified r100K-wt. Full scale fluorescence corresponds to 	5% consumption of substrate.
(B) The rate constant for the return of enzymatic activity. The time course at equivalent (3 nM) amounts of enzyme and inhibitor in (A) was fit
to an integrated first-order rate equation: y  vs*t 
 (vovs)(1  exp(k*t))/k 
 Ao. The solid line is theoretical for the return of activity with a
rate constant kcat  5.22  105 s1, equivalent to a half-life of 3 hr.
(C) 100K-wt (but not its D48A mutant) is very slowly cleaved by GrB. r100K (26 nM) (wt or D48A mutant) and 26 nM GrB were incubated either
alone for 180 min or in combination for various times at 37C. After terminating the reactions, samples were electrophoresed. r100K (wt and
mutant) and GrB were visualized by immunoblotting. The data was densitometrically scanned and used to calculate the percentage of intact
and cleaved proteins at each time point. Experiments were repeated on two separate occasions, with similar results.
mate of the duration of GrB inhibition in infected cells. viously used to induce apoptosis by GrB microinjection
(54 fg/cell) (Pinkoski et al., 1998).We quantified the amount of 100K/cell at different times
after adenovirus infection and compared this to the
amount of GrB/cell that becomes cell-associated in a Evolutionary Role of Asp-48 in 100K: Viral Versus
standard in vitro cytotoxicity assay. At 16 hr after infec- Inhibitory Function
tion with adenovirus, there was a 20-fold excess of 100K 100K assembly protein is an essential and multifunc-
over GrB, predicting a lag time of 90 hr before the tional protein in adenovirus and is absolutely required
return of GrB activity. At 48 hr after infection, the excess for efficient translation of late viral mRNA species and
of 100K increased to 34-fold, extending the lag phase also for hexon assembly. Consequently, ts mutants of
before the return of any GrB activity to 141 hr (Figure 100K are defective in late protein expression and virion
6A). Inhibition of GrB activity by 100K is therefore likely assembly (Cepko and Sharp, 1982; Hayes et al., 1990;
irreversible in adenovirus-infected cells. Since these es- Riley and Flint, 1993). To distinguish whether Asp-48
timates were obtained in an in vitro system that may plays a functional role in both adenovirus life cycle and
not adequately reflect infection or killing in vivo, these GrB inhibition, we determined the effect of native 100K
ratios may be different in vivo, influenced by the timing and 100K-D48A mutant on late protein expression and
of the killing event after infection, target cell susceptibil- GrB inhibitory activity in cells infected with the 100K
ity to granule-induced killing, and effector:target ratios. mutant virus H5ts1. At permissive temperature, H5ts1-
It is interesting that our estimate of target cell-associ- infected cells exhibited the wild-type pattern of produc-
tion of viral late proteins and inhibition of host cell trans-ated GrB (40 fg/cell) is very similar to the amount pre-
Granzyme B Inhibition by Adenovirus
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Figure 6. Physiologic Functions of Adenovi-
rus 100K
(A) 100K is produced at vast excess com-
pared to internalized GrB in Ad5-infected
293T cells exposed to potentially lethal doses
of GC. The predicted lag time before the re-
turn of GrB activity (t) is given by the equation:
t  (moles excess serpin)/(kcat  E).
(B and C) Asp-48 in 100K is required for GrB
inhibition, but not late gene expression in
H5ts1-infected cells. (B) 293T cells were
H5ts1-infected (10 pfu/cell) 12 hr after trans-
fection with empty vector, pcDNA3.1–100K,
or pcDNA3.1–100K-D48A and incubated at the
nonpermissive temperature (lanes 2, 3, and 4,
respectively). As a control, mock-transfected
cells were also incubated at the permissive
temperature (lane 1). At 30 hr after infection,
viral late proteins were metabolically labeled
and visualized by fluorography. (C) 100K wt,
but not the D48A mutant, protects H5ts1-
infected cells from cytotoxic granule-induced
cell death in vivo. 293T cells were trans-
fected/infected at the nonpermissive temper-
ature as described above and incubated with
GC. U1–70 kDa and active caspase-3 (New
England BioLabs) were detected by immu-
noblotting. The unfilled arrows denote protein
fragments.
lation (Figure 6B, lane 1) as well as GrB inhibitory activity Laskowski and Kato, 1980; Travis and Salvesen, 1983),
and unlike other serpins, 100K or its fragments do not(data not shown). In contrast, the suppression of host
cell translation and labeling of viral late proteins was form an SDS-stable complex with the enzyme (Quan et
al., 1995; Sun et al., 1996; Turner et al., 1999). And, fourth,significantly reduced in H5ts1-infected cells at nonper-
missive temperature (Figure 6B, lane 2), and no GrB unlike poxvirus-encoded serpins, in which a significant
contribution of antiapoptotic activity is from interferenceinhibitory activity was detected (Figure 6C, lane2). When
100K (either native or D48A mutant) was expressed by with caspase activity (Macen et al., 1996; Tewari et al.,
1995), 100K blocks cytotoxic granule-mediated death bytransfection in H5ts1-infected cells at nonpermissive
temperature, efficient inhibition of host cell translation exclusively inhibiting GrB without affecting the activity of
caspases.and robust virus late protein expression was observed
(Figure 6B, lanes 3 and 4). However, inhibition of GrB 100K inhibition of GrB is potent, rapidly established,
and involves the formation of a complex between inhibi-was only apparent when wild-type 100K was expressed
in the infected cells (Figure 6C, compare lane 4 to lanes tor and protease, which is cleaved extremely slowly
(kcat5.2 105 s1). Establishment of such a high-affinity2 and 6). These results demonstrate that 100K is the
only adenoviral protein that inhibits GrB, and that the complex, while maximizing sequestration of substrate, of-
ten occurs at the expense of subsequent precise orienta-D48A mutant (while incapable of GrB inhibition) is fully
functional in other viral pathways. Therefore, it is likely tion of the substrate within the catalytic machinery of the
protease (Jencks, 1969), likely explaining the extremelythat the GrB inhibitory effect of 100K evolved indepen-
dently of other functions of 100K. slow kcat. The inhibitory interaction involves a critical Asp
at position 48 in 100K, which is found within a classic
GrB consensus motif (IEQD48↓P). Once 100K is cleaved,Discussion
fragments dissociate and no longer inhibit GrB. Taken
together, these results are consistent with the nonstan-We have identified a potent and specific GrB inhibitor
dard serpin model proposed by Travis and Salvesenencoded by adenovirus that prevents GrB-induced apo-
(reviewed by Laskowski and Kato, 1980; Travis andptosis of infected target cells. 100K has numerous fea-
Salvesen, 1983). Such serpins form high-affinity inhibi-tures that are unique amongst viral protease inhibitors
tory complexes with their target serine proteases butthat inhibit apoptosis. First, in contrast with other viral
then slowly undergo catalysis with regeneration of enzy-inhibitors of apoptosis, which function exclusively in
matic activity. In the case of 100K, each enzyme-serpinpreventing apoptosis of the infected cell, 100K has other
complex turns over to products, on average, once everyessential functions in the adenovirus life cycle, including
3 hr. Since 100K is one of the most abundant proteinsvirus assembly and activation of late viral protein synthe-
produced by adenovirus (Cepko and Sharp, 1982) andsis (Cepko and Sharp, 1982; Hayes et al., 1990; Riley
likely accumulates to levels in infected cells that are inand Flint, 1993). Second, 100K is efficiently cleaved at
vast molar excess of GrB that enter cells during granule-several sites by GrB, only one of which (D48) plays any
induced killing, GrB inhibition is essentially irreversiblerole in inhibiting GrB. Third, 100K has no sequence ho-
mology with the serpin superfamily (reviewed by in adenovirus-infected cells.
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Adenoviruses have developed numerous strategies to GrB (F.A. et al., unpublished data). These proteins do
prevent apoptosis of infected target cells (reviewed in not inhibit GrB, and their cleavage is completely pre-
Wold et al., 1999). E1B19K, a product of early adenovirus vented by wild-type 100K. The evolution of 100K as
gene expression, functions analogously to bcl-2 and a potent inhibitor of GrB might therefore both protect
inhibits apoptosis induced by adenovirus E1A, p53, and infected target cells against GrB-mediated apoptosis
multiple other stimuli (reviewed in White, 1998). In addi- and inhibit GrB-mediated cleavage of viral proteins.
tion, E1B19K inhibits apoptosis by interfering with the Since granzymes have been identified as the preemi-
function of members of the Fas signaling complex (Imai nent effector molecules in cytotoxic lymphocyte-medi-
et al., 1999). In this study, we demonstrate that E1B19K ated control of some virus infections (Mullbacher et al.,
and/or other viral products are not responsible for the 1999; Riera et al., 2000), the existence of complementary
GrB inhibitory effect induced by adenovirus. First, 293 pathways of cytolysis by GrA and GrB may provide pro-
cells, an Ad5-transformed cell line that constitutively tection from pathogens that have evolved mechanisms
express E1B gene products (Graham et al., 1977; Aiello to evade one pathway or the other. Ad5 encodes multiple
et al., 1979) are susceptible to cytotoxic lymphocyte apoptosis inhibitors that target different components of
granule-induced cell death (Figures 2C, 3B–D, 4B, and the apoptosis pathway. It will be of great interest to
6C). Second, hydroxyurea treatment of Ad5-infected determine whether Ad5 encodes inhibitors of the GrA
HeLa cells (which allows only early gene expression, but pathway or whether (as we suspect) GrA plays a critical
not late gene expression) (data not shown) abolishes role in the host clearance of this pathogen.
adenovirus-encoded GrB inhibitory activity. Third, H5ts1 The discovery of adenovirus 100K as a potent and
virus (which efficiently expresses early genes at nonper- specific inhibitor of GrB offers a new tool to study the
missive temperature) is defective in inducing GrB inhibi- function of GrB in unique microenvironments in vivo. It
tory activity, and inhibitory activity is restored when the may also represent an important approach to decrease
mutant virus is rescued by coexpression of the wild- CTL-mediated responses in gene therapy and immune
type (Figures 3C and 6C), but not the D48A mutant form diseases in which the granule pathway plays a role (e.g.,
of 100K (Figure 6C). And, fourth, 100K expression alone graft rejection and autoimmunity).
is sufficient to inhibit GrB during cytotoxic granule-induced
cell death (Figures 3 and 4). Experimental Procedures
Viruses frequently use multiple mechanisms to evade
Cell Culture, Viral Infection, and Cell Transfectionimmune attack (reviewed in Tortorella et al., 2000), im-
HeLa and 293T cells were cultured using standard procedures. Con-plying incomplete protection from any single pathway
fluent monolayers were infected with wild-type Ad5 or the followingin vivo. Interestingly, adenovirus also expresses other
mutants: H5dl1011 (E4), H5E3::OAT2 (E3), H5dl1010 (E4-ORF6),
gene products that prevent cytolysis by CD8
 CTLs (re- H5dl1006 (E4-ORF1, -ORF2, -ORF3, and -ORF3/4), H5dl110
viewed in Wold et al., 1999). One of these proteins (E3gp- (E1B55), H5 ilE4J (all E4-ORFs are deleted, except E4-ORF6), and
19K) prevents MHC class I export from the ER to the cell H5ts1. Unless otherwise specified, cells were infected at 20–40 pfu/
cell, followed by incubation at 37C in a 5% CO2-humidified incuba-surface and blocks the killing of cells by CTLs. However,
tor, before performing biochemical analysis. H5ts1-infected cellssuch a strategy is of no use in preventing attack by NK
were incubated at permissive (33C) or nonpermissive (39C) tem-cells (reviewed in Tay et al., 1998), which similarly use the
peratures, as indicated in the figure legends. HeLa and 293T cells
cytotoxic granule pathway to achieve killing of infected were transfected using Lipofectamine 2000 (Gibco BRL) as recom-
target cells. 100K late protein may function to prevent mended by the manufacturer.
death induced by these additional cytolytic pathways.
Numerous cellular substrates are cleaved by GrB dur- Analysis of GC-, LAK-, and UVB-Induced Apoptosis
ing target cell death, including the proapoptotic mole- Apoptosis was induced by UVB irradiation of HeLa cells, and the cell
lysates were analyzed as described (Casciola-Rosen et al., 1999).cule BID (Li et al., 1998; Barry et al., 2000; Heibein et
Isolation of GC from human GrA-deficient YT cells and purificational., 2000; Sutton et al., 2000), DFF45/ICAD (Thomas et
of GrB was performed as described (Andrade et al., 1998). HeLa oral., 2000), and several downstream substrates involved
293T cells were washed with Ca2
-free Hanks’ balanced salt solution
in cellular homeostasis (Froelich et al., 1996; Andrade (HBSS) containing 10 mM HEPES (pH 7.4), carefully detached with
et al., 1998; Casciola-Rosen et al., 1999). Interestingly, a cell lifter (HeLa cells) or by gentle pipeting (293T cells), incubated
100K itself is efficiently cleaved by GrB when its inhibi- in the presence or absence of GC at 37C for 90 min, and analyzed
as described (Andrade et al., 1998). For MitoSensor analysis, 293Ttory site (Asp-48) is mutated. Furthermore, the 100K-
cells were detached by trypsin/EDTA (Gibco BRL) treatment,D48A mutant is incapable of GrB inhibition, but remains
washed twice with DMEM containing 10% fetal serum, and after 2functional in other viral pathways, suggesting that GrB
hr incubation at 4C, cells were washed twice in HBSS/HEPES andinhibition evolved independently of other functions of
incubated in the absence or presence of GC. Mitosensor labeling
100K. We propose that a loop within 100K (which was was performed according to the manufacturer’s instructions (Clon-
cleaved by GrB) mutated to become an effective inhibi- tech). LAK cells were prepared as described (Andrade et al., 1998).
tor of this protease, preventing cleavage of viral and Fas-negative 293T target cells were detached with trypsin/EDTA,
resuspended at 2 106 cells/ml, and coincubated with LAK effectorcellular substrates, and was positively selected due to
cells for 4 hr. After washing, cells were lysed and boiled in SDSits positive impact on viral replication. 100K, therefore,
sample buffer and immunoblotted as described (Andrade et al.,represents a novel class of viral protease inhibitors, in
1998).which an essential, multifunctional viral protein that is
vulnerable to specific proteolysis by GrB expresses in-
GrB Cleavage of Endogenous Substrates in Cell Lysates
hibitory function against that protease. Cell lysates were prepared as described (Andrade et al., 1998) and
In addition to 100K, we have identified that the adeno- incubated at 37C for 60 min in the presence or absence of GC or
virus single-stranded DNA binding protein and hexon, its equivalent amount of purified GrB (42 nM). The reactions were
stopped by boiling in SDS-sample buffer, and 75 g aliquots wereits major coat protein, are also efficiently cleaved by
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electrophoresed in each gel lane. Intact autoantigens and their spe- Confocal Immunofluorescence Microscopy
Morphologic experiments were performed on cells grown on numbercific GrB cleavage fragments were visualized by immunoblotting as
described (Casciola-Rosen et al., 1999). 1 glass coverslips as described (Andrade et al., 1998).
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